These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21317396)

  • 1. Inducible adeno-associated virus-mediated IL-2 gene therapy prevents autoimmune diabetes.
    Goudy KS; Johnson MC; Garland A; Li C; Samulski RJ; Wang B; Tisch R
    J Immunol; 2011 Mar; 186(6):3779-86. PubMed ID: 21317396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
    Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-beta1 somatic gene therapy prevents autoimmune disease in nonobese diabetic mice.
    Piccirillo CA; Chang Y; Prud'homme GJ
    J Immunol; 1998 Oct; 161(8):3950-6. PubMed ID: 9780163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The type and frequency of immunoregulatory CD4+ T-cells govern the efficacy of antigen-specific immunotherapy in nonobese diabetic mice.
    Pop SM; Wong CP; He Q; Wang Y; Wallet MA; Goudy KS; Tisch R
    Diabetes; 2007 May; 56(5):1395-402. PubMed ID: 17317763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retroviral delivery of GAD-IgG fusion construct induces tolerance and modulates diabetes: a role for CD4+ regulatory T cells and TGF-beta?
    Song L; Wang J; Wang R; Yu M; Sun Y; Han G; Li Y; Qian J; Scott DW; Kang Y; Soukhareva N; Shen B
    Gene Ther; 2004 Oct; 11(20):1487-96. PubMed ID: 15343360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant adeno-associated virus-mediated alpha-1 antitrypsin gene therapy prevents type I diabetes in NOD mice.
    Song S; Goudy K; Campbell-Thompson M; Wasserfall C; Scott-Jorgensen M; Wang J; Tang Q; Crawford JM; Ellis TM; Atkinson MA; Flotte TR
    Gene Ther; 2004 Jan; 11(2):181-6. PubMed ID: 14712302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of IL-2 in β cells by AAV8 gene transfer in pre-diabetic NOD mice prevents diabetes through activation of FoxP3-positive regulatory T cells.
    Flores RR; Zhou L; Robbins PD
    Gene Ther; 2014 Aug; 21(8):715-22. PubMed ID: 24849041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic paracrine TGF-beta1.
    Moritani M; Yoshimoto K; Wong SF; Tanaka C; Yamaoka T; Sano T; Komagata Y; Miyazaki J; Kikutani H; Itakura M
    J Clin Invest; 1998 Aug; 102(3):499-506. PubMed ID: 9691086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene delivery GAD 500 autoantigen by AAV serotype 1 prevented diabetes in NOD mice: transduction efficiency do not play important roles.
    Han G; Wang R; Chen G; Wang J; Xu R; Feng J; Yu M; Wu X; Qian J; Shen B; Li Y
    Immunol Lett; 2008 Jan; 115(2):110-6. PubMed ID: 18045698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-cell-specific IL-35 therapy suppresses ongoing autoimmune diabetes in NOD mice.
    Manzoor F; Johnson MC; Li C; Samulski RJ; Wang B; Tisch R
    Eur J Immunol; 2017 Jan; 47(1):144-154. PubMed ID: 27859048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M; Piccirillo CA
    J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice.
    Goudy K; Song S; Wasserfall C; Zhang YC; Kapturczak M; Muir A; Powers M; Scott-Jorgensen M; Campbell-Thompson M; Crawford JM; Ellis TM; Flotte TR; Atkinson MA
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13913-8. PubMed ID: 11717448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of regulatory T-cell induction by antigen-IgG-transduced splenocytes.
    Wang R; Song L; Han G; Wang J; Chen G; Xu R; Yu M; Qian J; Shen B; Li Y
    Scand J Immunol; 2007 Nov; 66(5):515-22. PubMed ID: 17883389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of transgenic expression of TGF-beta1 on transplanted islet graft survival.
    Yamasaki S; Kurita N; Hata J; Moritani M; Itakura M; Shimada M
    Hepatogastroenterology; 2007 Sep; 54(78):1617-21. PubMed ID: 18019678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pro-apoptotic DNA vaccination ameliorates new onset of autoimmune diabetes in NOD mice and induces foxp3+ regulatory T cells in vitro.
    Li A; Ojogho O; Franco E; Baron P; Iwaki Y; Escher A
    Vaccine; 2006 Jun; 24(23):5036-46. PubMed ID: 16621191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-beta1 production by CD4+ CD25+ regulatory T cells is not essential for suppression of intestinal inflammation.
    Kullberg MC; Hay V; Cheever AW; Mamura M; Sher A; Letterio JJ; Shevach EM; Piccirillo CA
    Eur J Immunol; 2005 Oct; 35(10):2886-95. PubMed ID: 16180248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intramuscular administration of expression plasmids encoding interferon-gamma receptor/IgG1 or IL-4/IgG1 chimeric proteins protects from autoimmunity.
    Chang Y; Prud'homme GJ
    J Gene Med; 1999; 1(6):415-23. PubMed ID: 10753067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Essential roles of TGF-beta in anti-CD3 antibody therapy: reversal of diabetes in nonobese diabetic mice independent of Foxp3+CD4+ regulatory T cells.
    Chen G; Han G; Wang J; Wang R; Xu R; Shen B; Qian J; Li Y
    J Leukoc Biol; 2008 Feb; 83(2):280-7. PubMed ID: 18029395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intramuscular transfer of naked calcitonin gene-related peptide gene prevents autoimmune diabetes induced by multiple low-dose streptozotocin in C57BL mice.
    Sun W; Wang L; Zhang Z; Chen M; Wang X
    Eur J Immunol; 2003 Jan; 33(1):233-42. PubMed ID: 12594852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice.
    Shapiro AM; Suarez-Pinzon WL; Power R; Rabinovitch A
    Diabetologia; 2002 Feb; 45(2):224-30. PubMed ID: 11935154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.